The insolvency administrator of Germany-based Greensill Bank AG has launched court proceedings against Insurance Australia Limited seeking US$35 million allegedly owed under a policy indemnifying the collapsed financial services firm for unrecovered debts.
Supermarket chain Romeo’s has reached a settlement in two class actions alleging staff were underpaid, but details of the agreements are scant.
Generic drug maker Sandoz AG has filed proceedings seeking the revocation of two patents registered in Australia by German pharmaceutical giant Bayer covering its top-selling blood clot drug Xarelto.
Two former barristers ordered to pay at least $21.7 million in damages and costs for their role in a fraudulent scheme to pocket a windfall from the Banksia Securities class action have filed for bankruptcy.
Five years into a preliminary discovery application for a potential patent infringement lawsuit over a biosimilar of its Enbrel medication, Pfizer has partially succeeded in obtaining further documents from Samsung Bioepis.
A judge has extended asset freezing orders until next year in a $109.5 million case brought by the tax office against Gold Coast property developer James Raptis and his companies.
The Australian Securities and Investments Commission has asked a court to hold Mayfair 101 director James Mawhinney in contempt, saying he has breached a 20-year ban on raising funds.
Pharmaceutical ingredient producer Alkaloids of Australia has pleaded guilty to cartel conduct over the supply of a key chemical found in generic stomach cramp drugs.
A Nyamal man mistakenly identified by the Seven Network as the suspect in the abduction of four-year-old Cleo Smith in Western Australia is suing the broadcaster for defamation.
Changes negotiated to the Andrews government’s controversial pandemic bill fall short of protecting the rule of law, Victorian Bar head Róisín Annesley QC said Tuesday.